Who has invested in Psivant Therapeutics?

Lightstone Ventures, Samsara BioCapital, Roivant, YK Bioventures, Eurofarma Ventures are named among the investors backing Psivant Therapeutics.

Psivant Therapeutics Funding: $50M Raised, Series A (2024)

Psivant Therapeutics funding overview

Psivant Therapeutics is a Biotech company based in Boston. Psivant Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2024. The round record for Psivant Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Lightstone Ventures, Samsara BioCapital, Roivant, YK Bioventures, Eurofarma Ventures. 5 distinct backers are named across the disclosed rounds.

Psivant Therapeutics at a glance

Total raised: $50M
Latest round: Series A
Latest round date: March 2024
Industry: Biotech
Headquarters: Boston
Notable investors: Lightstone Ventures, Samsara BioCapital, Roivant, YK Bioventures, Eurofarma Ventures

Frequently asked about Psivant Therapeutics funding

How much has Psivant Therapeutics raised?: Psivant Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Psivant Therapeutics?: Lightstone Ventures, Samsara BioCapital, Roivant, YK Bioventures, Eurofarma Ventures are named among the investors backing Psivant Therapeutics.
What was the latest Psivant Therapeutics funding round?: The most recent disclosed round is a Series A, announced in March 2024.
Where is Psivant Therapeutics based?: Psivant Therapeutics is based in Boston.
What sector does Psivant Therapeutics operate in?: Psivant Therapeutics is tracked under Biotech from Boston, with $50M in disclosed funding.
When did Psivant Therapeutics last raise?: The last disclosed Psivant Therapeutics round closed in March 2024 at Series A.

Psivant Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Boston below to benchmark round size and investor mix.

Psivant Therapeutics Funding: $50M Raised, Series A (2024)

Psivant Therapeutics funding overview

Psivant Therapeutics at a glance

Frequently asked about Psivant Therapeutics funding

Companies related to Psivant Therapeutics (40)

Browse related funding lists (7)